TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
CGON

CG Oncology, Inc.

Healthcare · Biotechnology

75.60$ +2.0% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns CG Oncology, Inc. (CGON)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 73.0% of the shares are freely tradable; institutional investors hold 109.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 109.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 73.0%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 13.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 89Mio.

Largest Shareholders

Institutions

Institutions CGON
Name Stake (%) Shares Change (%) Date
RTW INVESTMENTS, LLC 7.88 6,984,808 +247.1 03/31/2026
T. Rowe Price Investment Management,Inc. 7.58 6,720,389 +1,347.0 03/31/2026
Decheng Capital LLC 7.19 6,371,669 +0.0 03/31/2026
Wellington Management Company LLP 6.01 5,324,751 -0.9 06/30/2026
BlackRock Inc 5.71 5,064,180 +4.6 03/31/2026
FMR Inc 4.25 3,764,844 -12.4 03/31/2026
TCG Crossover Management, LLC 4.14 3,670,206 +0.0 06/30/2026
T. Rowe Price Associates, Inc. 4.12 3,652,980 +6.1 03/31/2026
Vanguard Portfolio Management, LLC 3.49 3,095,098 +0.0 03/31/2026
Vanguard Capital Management, LLC 3.42 3,033,625 +0.0 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 14, 2026 Post Leonard E Director Sell 1,000 74.54 74,540
Aug 14, 2026 Post Leonard E Director Other 1,000 0.60 600
Jul 15, 2026 Post Leonard E Director Sell 1,000 71.17 71,170
Jul 15, 2026 Post Leonard E Director Other 1,000 0.60 600
Jul 10, 2026 Mulay James Director Sell 24,165 75.16 1,816,241
Jul 10, 2026 Mulay James Director Other 24,165 26.63 643,514
Apr 17, 2026 James Mulay Director Sell 15,600 73.01 1,138,956

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?